AbbVie Announces Offer Consideration for Acquisition of Pharmacyclics
Go back to AbbVie Announces Offer Consideration for Acquisition of Pharmacyclics| AbbVie (NYSE: ABBV) | Delayed: 263.04 -3.24 (1.22%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $266.28 | 52 Week High | $68.12 | |||
| Open | $265.45 | 52 Week Low | $50.71 | |||
| Day High | $268.93 | P/E | 57.06 | |||
| Day Low | $261.52 | EPS | $4.61 | |||
| Volume | 782,144 | |||||
